Human Review Misses Too Many Erroneous AI Recommendations
Artificial intelligence is moving deeper into routine care, but this review makes one point hard to ignore: human oversight does not automatically neutralize bad machine advice. When clinicians were presented with incorrect automated guidance, their responses depended heavily on whether the advice appeared correct or flawed, and the gap was large. Across three adjusted cohorts, clinician correctness was far higher when the automated output was correct than when it was wrong, with a pooled odds ratio of 10.19 (95% CI 7.43–13.98; I² = 0%).
The practical danger is not abstract. Clinical decision support systems can anchor judgment, narrow differential diagnosis, and make an erroneous recommendation feel familiar enough to accept at the bedside. In that setting, the human reviewer is not acting as a fail-safe; the reviewer can become part of the failure mode.
What the Meta-Analysis Actually Examined
The review assembled 46 reports spanning 41 independent cohort clusters, including 40 core cohorts. Its central question was narrow and clinically important: when automated advice is wrong, do clinicians reliably detect the error and override it? The answer varied by setting, by technology, and by how the studies measured clinician response.
A sensitivity analysis restricted to studies from 2020 onward pointed in the same direction, although the estimate became imprecise. The pooled odds ratio remained strong at 9.22, with a wide confidence interval of 2.06–41.13. Even with that uncertainty, the direction of effect did not change. Clinicians were still much more likely to be correct when the automated recommendation was correct than when it was incorrect.
That pattern matters because it suggests an asymmetry in human-machine interaction. Clinicians may be good at confirming a plausible recommendation, but less reliable at intercepting a plausible error. In practice, those two tasks are not the same.
Erroneous ECG Interpretations Slipped Through in Real-World Use
The clearest real-world signal came from four heterogeneous computerized ECG studies. In those cohorts, 26.6% of erroneous interpretations were not corrected or recognized, with a 95% confidence interval ranging from 6.4% to 65.6% and very high heterogeneity (I² = 95.8%). The spread is wide, but the signal is unmistakable: a meaningful share of wrong outputs survived human review.
ECG interpretation is an especially revealing test case because the output is often treated as a rapid triage tool rather than a final diagnosis. Automated flags can accelerate workflow, yet they can also create an illusion of precision. When an erroneous tracing interpretation lands inside a busy clinical environment, especially one with competing demands, the reviewing clinician may defer to the machine rather than challenge it. A system built to speed recognition can therefore speed error propagation.
Contemporary AI and Large Language Model Studies Raised Similar Concerns
Studies involving contemporary AI systems and large language models also documented harmful reliance, but the evidence was too heterogeneous for quantitative pooling. Even so, the consistency of the signal across older decision-support tools and newer AI systems points to the same core problem: oversight works only when the human reviewer is positioned to detect the mistake, has time to do so, and is not unduly swayed by the machine’s apparent confidence.
This is a cognitive problem as much as a technical one. Clinicians do not review recommendations in a vacuum. They work under time pressure, in environments that reward speed, and often with output that appears polished, authoritative, and consistent with prior expectations. A fluent system can sound right and still be wrong. In the context of clinical AI, fluency is not safety.
Patient Harm Was Reported, But Evidence Remained Sparse
Patient-level adverse events appeared in one retrospective cohort. That is a limited safety signal, not a complete account of harm, but it matters because the endpoint most relevant to patients is not whether a clinician agrees with a machine. It is whether an incorrect recommendation changes treatment, delays care, or causes avoidable injury.
The review’s framing is therefore clinically important. Human oversight should be judged as an error-interception mechanism, not as an assumed safeguard. A reviewer who rarely catches wrong output cannot be treated as a reliable control layer, especially when the underlying system is being deployed in high-stakes settings such as cardiac interpretation, triage support, imaging review, or language-model-driven documentation.
Why the Safety Argument Needs to Change
The usual promise around clinical AI is that a human remains in the loop. This review suggests that phrase is too reassuring unless it is defined operationally. A human in the loop can confirm an accurate recommendation, but that does not prove the same human will spot a subtle falsehood. Oversight has to be measured by interception rate, not by presence alone.
For hospital systems, the implications are immediate. Validation studies should test how often clinicians actually override wrong outputs, not just whether they like the interface or trust the model. Training should focus on known failure patterns, especially cases where machine advice is confident, plausible, and wrong. Governance teams should also distinguish between tools that support recall and tools that can actively mislead judgment.
The review does not prove that AI is unsafe in every use case. It does show that safety cannot be inferred from the existence of human review. When erroneous advice is accepted often enough, the reviewer is no longer a backstop; the reviewer becomes another pathway through which the error reaches the patient.
Evidence Gaps That Still Need Direct Study
The dataset also leaves important questions unresolved. The included studies were diverse, and the heterogeneity in real-world ECG work was extreme. Contemporary AI and large language model studies could not be pooled, which limits direct comparison across platforms and clinical tasks. Only one retrospective cohort reported patient-level adverse events, leaving a thin safety literature around actual downstream harm.
Future evaluations will need to move beyond whether a system improves efficiency and ask whether it reliably prevents wrong advice from shaping care. Until then, the strongest message from this review is a restrained one: human oversight is not a guarantee, and in some settings it is failing to catch enough errors to be treated as a dependable safety net.